Lun Wang

Yixian Shen, Hang Zhang, Yanxin Shen et al.

Digital accessibility is a cornerstone of inclusive content delivery, yet many EPUB files fail to meet fundamental accessibility standards, particularly in providing descriptive alt text for images. Alt text plays a critical role in enabling visually impaired users to understand visual content through assistive technologies. However, generating high-quality alt text at scale is a resource-intensive process, creating significant challenges for organizations aiming to ensure accessibility compliance. This paper introduces AltGen, a novel AI-driven pipeline designed to automate the generation of alt text for images in EPUB files. By integrating state-of-the-art generative models, including advanced transformer-based architectures, AltGen achieves contextually relevant and linguistically coherent alt text descriptions. The pipeline encompasses multiple stages, starting with data preprocessing to extract and prepare relevant content, followed by visual analysis using computer vision models such as CLIP and ViT. The extracted visual features are enriched with contextual information from surrounding text, enabling the fine-tuned language models to generate descriptive and accurate alt text. Validation of the generated output employs both quantitative metrics, such as cosine similarity and BLEU scores, and qualitative feedback from visually impaired users. Experimental results demonstrate the efficacy of AltGen across diverse datasets, achieving a 97.5% reduction in accessibility errors and high scores in similarity and linguistic fidelity metrics. User studies highlight the practical impact of AltGen, with participants reporting significant improvements in document usability and comprehension. Furthermore, comparative analyses reveal that AltGen outperforms existing approaches in terms of accuracy, relevance, and scalability.

Lun Wang, Chuanqi Shi, Shaoshui Du et al.

This paper presents a comprehensive performance evaluation of Large Language Models (LLMs) in solving programming challenges from Leetcode, a widely used platform for algorithm practice and technical interviews. We began by crawling the Leetcode website to collect a diverse set of problems encompassing various difficulty levels and topics. Using this dataset, we generated solutions with multiple LLMs, including GPT-4 and GPT-3.5-turbo (ChatGPT-turbo). The generated solutions were systematically evaluated for correctness and efficiency. We employed the pass@k metric to assess the success rates within a given number of attempts and analyzed the runtime performance of the solutions. Our results highlight the strengths and limitations of current LLMs [10] in code generation and problem-solving tasks, providing insights into their potential applications and areas for improvement in automated programming assistance.

Xuanzhong Chen, Ye Jin, Xiaohao Mao et al.

Rare diseases, despite their low individual incidence, collectively impact around 300 million people worldwide due to the vast number of diseases. The involvement of multiple organs and systems, and the shortage of specialized doctors with relevant experience, make diagnosing and treating rare diseases more challenging than common diseases. Recently, agents powered by large language models (LLMs) have demonstrated notable applications across various domains. In the medical field, some agent methods have outperformed direct prompts in question-answering tasks from medical examinations. However, current agent frameworks are not well-adapted to real-world clinical scenarios, especially those involving the complex demands of rare diseases. To bridge this gap, we introduce RareAgents, the first LLM-driven multi-disciplinary team decision-support tool designed specifically for the complex clinical context of rare diseases. RareAgents integrates advanced Multidisciplinary Team (MDT) coordination, memory mechanisms, and medical tools utilization, leveraging Llama-3.1-8B/70B as the base model. Experimental results show that RareAgents outperforms state-of-the-art domain-specific models, GPT-4o, and current agent frameworks in diagnosis and treatment for rare diseases. Furthermore, we contribute a novel rare disease dataset, MIMIC-IV-Ext-Rare, to facilitate further research in this field.